Literature DB >> 7233186

Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema.

G W Hunninghake, J M Davidson, S Rennard, S Szapiel, J E Gadek, R G Crystal.   

Abstract

This study suggests one mechanism by which alveolar macrophages accumulate in the lung in pulmonary emphysema: elastin fragments generated at the diseased sites are potent chemoattractants for monocytes, the precursors of the macrophages. The most chemotactic elastin fragments have a molecular weight between 10,000 and 50,000 and are active at concentrations as low as 3 nanograms per milliliter. By comparison, elastin fragments with higher molecular weights and desmosines are active at concentrations greater than 0.3 microgram per milliliter. In addition, preincubation of monocytes with the 10,000- to 50,000-dalton elastin impairs the ability of the cells to migrate toward elastin fragments but not toward activated serum. Fragments of tropoelastin are not chemotactic for monocytes. Because elastin, but not tropoelastin, contains lysyl-derived cross-links, these structures may be the active chemotactic site on the elastin fragments.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7233186     DOI: 10.1126/science.7233186

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  62 in total

Review 1.  Recent advances in molecular biological techniques and their relevance to pulmonary research.

Authors:  B W Robinson; D J Erle; D A Jones; S Shapiro; W J Metzger; S M Albelda; W C Parks; A Boylan
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

Review 2.  Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema.

Authors:  R Mahadeva; S D Shapiro
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

3.  Immunolocalization of 67 kDa elastin-binding protein in perinatal rat lungs.

Authors:  K Wasano; Y Hirakawa; K Nakamura
Journal:  Cell Tissue Res       Date:  1992-05       Impact factor: 5.249

Review 4.  The impact of the extracellular matrix on inflammation.

Authors:  Lydia Sorokin
Journal:  Nat Rev Immunol       Date:  2010-10       Impact factor: 53.106

Review 5.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

6.  Serum cystatin C as a potential biomarker for the evaluation COPD.

Authors:  Yonghong Zhang; Yanting Zhu; Yuanyuan Wu; Guizuo Wang; Xinming Xie; Rui Ke; Shaojun Li; Lu Liu; Wei Fen; Fengjuan Li; Fangxia Li; Manxiang Li
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 7.  Matrix metalloproteinases in emphysema.

Authors:  Sina A Gharib; Anne M Manicone; William C Parks
Journal:  Matrix Biol       Date:  2018-03-23       Impact factor: 11.583

8.  TGF-β (Transforming Growth Factor-β) Signaling Protects the Thoracic and Abdominal Aorta From Angiotensin II-Induced Pathology by Distinct Mechanisms.

Authors:  Stoyan N Angelov; Jie Hong Hu; Hao Wei; Nathan Airhart; Minghui Shi; David A Dichek
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-07-20       Impact factor: 8.311

Review 9.  Pathogenesis of emphysema: from the bench to the bedside.

Authors:  Amir Sharafkhaneh; Nicola A Hanania; Victor Kim
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

10.  Demonstration of elastin gene expression in human skin fibroblast cultures and reduced tropoelastin production by cells from a patient with atrophoderma.

Authors:  M G Giro; A I Oikarinen; H Oikarinen; G Sephel; J Uitto; J M Davidson
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.